Mustang Bio, Inc. (MBIO)
$0.38-7.32%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- 2.09
- P/E (TTM)
- -0.84
- Short % float
- 0.82%
- Days to cover
- 1.7
- SI change
- -10.0%
- 1W
- -17.39%
- 1M
- -25.49%
- vs SPY 1W
- -17.25%
- vs SPY 1M
- -28.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on MBIO?
- LOPJLB’s latest quantitative signal on Mustang Bio, Inc. (MBIO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is MBIO in?
- Mustang Bio, Inc. (MBIO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Mustang Bio, Inc. (MBIO) do?
- Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; …